Stocks Slip on 3Q Earnings Results

U.S. stocks slipped from two-week highs on Tuesday as results and outlooks from companies in various sectors, including housing and consumer products, failed to live up to expectations.

Novartis profit slips as key drug goes generic

Swiss drug company Novartis saw net profit slip in the third quarter as the loss of a key drug to generic use in the United States outweighed strong sales of its psoriasis drug Cosentyx and MS treatment Gilenya.